Clinical trial
Safety and Efficacy Evaluation of the Dose Regimen of Vitamin D 50,000 IU(Biodal) Tablet Supplementation in the Treatment of Population With Vitamin D Deficiency.
NCT02192229 is registered in ClinicalTrials.gov with Hayat Pharmaceutical Co. PLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Evaluation of the Dose Regimen of Vitamin D 50,000 IU(Biodal) Tablet Supplementation in the Treatment of Population With Vitamin D Deficiency.
- Lead sponsor
- Hayat Pharmaceutical Co. PLC
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2014
- Completion date
- November 30, 2014
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.